Jonathan Rubin Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity
Jonathan Rubin is SVP, Chief Medical Officer of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 9,635 shares of SUPN, which is worth approximately $308,994. The most recent transaction as insider was on Mar 05, 2025, when has been sold 1,468 shares (Common Stock) at a price of $33.05 per share, resulting in proceeds of $48,517. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
9.64K
107.61%
3M change
107.61%
12M change
Total Value Held
$308,994
Jonathan Rubin Transaction History
JR
Jonathan Rubin
SVP, Chief Medical Officer
Rockville, MD